Takeuchi, "Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate," International Journal of Pharmaceutics, vol.
Drug Method Key ingredients PSD ([micro]m) Pranlukast SD Pharmatose 200 M and <90 hydrate Pharmatose 325 M Human serum SD Albumin : lactose: DPPC 6.50 albumin (30 : 10 : 60) SS SD Lactochem crystals 7772 Budesonide SD [alpha]-LM >230 Drug Device and flow % FPF References rate (l/min) Pranlukast Spinhaler[R] 28.5 [+ or -] 3.1 [35] hydrate and 60 Human serum Spinhaler and 41 [+ or -] 5.0 [36] albumin 28.3 SS Cyclohaler and 31.3 [+ or -] 1.3 [37] 60 Budesonide Thaifun[R] 31.0 [+ or -] 5.1 [38] * Taifun is a multiple dose, reservoir-based DPI.
Indeed, the CysLTR-1 antagonist pranlukast did not reduce the accumulation of microglia in the ischemic cerebral cortex [49], while HAMI 3379 significantly attenuated the number of microglia in the ischemic core and in the boundary zone [50].
Pranlukast inhibited acute, subacute, and chronic ischemic injury in the brains of mice and rats after focal cerebral ischemia [15,49,65,78].
carbama-zepina, ciclosporina, cilostazol, cisapride, clindamicina, clomipramina, clonazpam, clopidogrel, c ocaina, dapsona, dexameta- sona, dextrometorfan, diazepam, diltiazem, eritromicina, estrogenos, etosuximida, fluticasona, imipramina, indinavir, isradi- pino, ketoconazol, lansoprazol, lidocaina, lovastatina, mibefradil, midazolam, nifedi-pina, nimodipina, paricalcitol, pioglitazona,
pranlukast, pravastatina, prednisolona, quinina, rifampicina, ranolaxine, repagli-nida, rimonabant, ritonavir, sertralina, sildenafil, simvastatina, sirolimus, sitaglip-tina, tacrolimus, tadalofilo, tamsulosina, terfenadina, pruebaosterona, triazolam, valdenafil, verapamilo, warfarina, zolpidem.